Stereotactic body radiotherapy for frail patients with primary renal cell carcinoma: preliminary results after 4 years of experience

HIGHLIGHTS

• who: Laure Grelier et al. from the Department of Urology and Kidney Transplantation, Aix-Marseille University, Assistance Publique-Hôpitaux have published the paper: Stereotactic Body Radiotherapy for Frail Patients with Primary Renal Cell Carcinoma: Preliminary Results after 4 Years of Experience, in the Journal: Cancers 2021, 13, 3129. of 26/05/2021
• what: The aim of this study was to report the oncological outcomes and toxicity of stereotactic body radiotherapy (SBRT) to treat primary renal cell carcinoma (RCC) in frail patients unfit for surgery or standard alternative ablative therapies. And following a review of . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.